0 Bedömningar
ID

28021

Beskrivning

NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma. Visit: All visits. Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz

Nyckelord

Versioner (2)
  1. 2017-12-10 2017-12-10 -
  2. 2018-01-02 2018-01-02 -
Rättsinnehavare

Prof. Dr. med. Georg Heß

Uppladdad den

10 december 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

  • Senaste
  • Äldsta
  • Önskad
  • Senaste
    • Senaste
    • Äldsta
    • Önskad

    Inga kommentarer

    Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

    Adverse events GOAL Trial B-cell Lymphoma NCT02499003

    Engelsk

    Adverse events GOAL Trial B-cell Lymphoma NCT02499003

    1 Formulär  
    Admininstrative data
    Beskrivning

    Admininstrative data

    Subject ID
    Beskrivning

    Subject ID

    Datatyp

    text

    Alias
    UMLS CUI [1]
    C2348585 (Clinical Trial Subject Unique Identifier)
    Page
    Beskrivning

    Page

    Datatyp

    integer

    Adverse events
    Beskrivning

    Adverse events

    No.
    Beskrivning

    adverse event number

    Datatyp

    integer

    AE Term (based on CTCAE 4.0)
    Beskrivning

    Adverse event

    Datatyp

    text

    SAE?
    Beskrivning

    Serious adverse event

    Datatyp

    text

    Study termination
    Beskrivning

    Study termination

    Datatyp

    text

    Start date
    Beskrivning

    Start date

    Datatyp

    date

    Stop date
    Beskrivning

    Stop date

    Datatyp

    date

    Ongoing at End of Treatment?
    Beskrivning

    Ongoing adverse event at End of Treatment

    Datatyp

    boolean

    Max. CTCAE grade
    Beskrivning

    Maximum CTCAE grade

    Datatyp

    integer

    Causality with Obinutuzumab
    Beskrivning

    Causality with Obinutuzumab

    Datatyp

    integer

    Causality with Pixantrone
    Beskrivning

    Causality with Pixantrone

    Datatyp

    integer

    Action taken with Obinutuzumab
    Beskrivning

    Action taken with Obinutuzumab

    Datatyp

    integer

    Action taken with Pixantrone
    Beskrivning

    Action taken with Pixantrone

    Datatyp

    integer

    Treatment given?
    Beskrivning

    Treatment

    Datatyp

    text

    Outcome
    Beskrivning

    Treatment Outcome

    Datatyp

    integer

    I have reviewed the AEs on this page and have assessed them for seriousness, causality, severity and outcome and confirm that, to the best of my knowledge, they accurately reflect the study information obtained for this patient.
    Beskrivning

    I have reviewed the AEs on this page and have assessed them for seriousness, causality, severity and outcome and confirm that, to the best of my knowledge, they accurately reflect the study information obtained for this patient.

    Data correct?
    Beskrivning

    Data correct

    Datatyp

    boolean

    Date of signature
    Beskrivning

    Date of signature

    Datatyp

    date

    Name of investigator
    Beskrivning

    Name of investigator

    Datatyp

    text

    Tillbaka till toppen

    Similar models

    Adverse events GOAL Trial B-cell Lymphoma NCT02499003

    1 Formulär
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datatyp
    Alias
    Item Group
    Admininstrative data
    Subject ID
    Item
    Subject ID
    text
    C2348585 (UMLS CUI [1])
    Page
    Item
    Page
    integer
    Item Group
    Adverse events
    Item
    No.
    integer
    adverse event number
    Code List
    No.
    CL Item
    01 (1)
    CL Item
    02 (2)
    CL Item
    03 (3)
    CL Item
    04 (4)
    CL Item
    05 (5)
    CL Item
    06 (6)
    CL Item
    07 (7)
    CL Item
    08 (8)
    CL Item
    09 (9)
    CL Item
    10 (10)
    Adverse event
    Item
    AE Term (based on CTCAE 4.0)
    text
    Serious adverse event
    Code List
    SAE?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Item
    Study termination
    text
    Serious adverse event
    Code List
    Study termination
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Start date
    Item
    Start date
    date
    Stop date
    Item
    Stop date
    date
    Ongoing adverse event at End of Treatment
    Item
    Ongoing at End of Treatment?
    boolean
    Maximum CTCAE grade
    Item
    Max. CTCAE grade
    integer
    Item
    Causality with Obinutuzumab
    integer
    Causality with Obinutuzumab
    Code List
    Causality with Obinutuzumab
    CL Item
    Not related (1)
    CL Item
    Related (2)
    Item
    Causality with Pixantrone
    integer
    Causality with Obinutuzumab
    Code List
    Causality with Pixantrone
    CL Item
    Not related (1)
    CL Item
    Related (2)
    Item
    Action taken with Obinutuzumab
    integer
    Action taken with Obinutuzumab
    Code List
    Action taken with Obinutuzumab
    CL Item
    Unchanged (1)
    CL Item
    Reduced (2)
    CL Item
    Interrupted (3)
    CL Item
    Discontinued (4)
    CL Item
    Not applicable (5)
    Item
    Action taken with Pixantrone
    integer
    Action taken with Obinutuzumab
    Code List
    Action taken with Pixantrone
    CL Item
    Unchanged (1)
    CL Item
    Reduced (2)
    CL Item
    Interrupted (3)
    CL Item
    Discontinued (4)
    CL Item
    Not applicable (5)
    Item
    Treatment given?
    text
    Serious adverse event
    Code List
    Treatment given?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Item
    Outcome
    integer
    Treatment Outcome
    Code List
    Outcome
    CL Item
    Recovered (1)
    CL Item
    Recovered with sequelae (2)
    CL Item
    Recovering (3)
    CL Item
    Not recovered (4)
    CL Item
    Fatal (5)
    CL Item
    Unknown (6)
    Item Group
    I have reviewed the AEs on this page and have assessed them for seriousness, causality, severity and outcome and confirm that, to the best of my knowledge, they accurately reflect the study information obtained for this patient.
    Data correct
    Item
    Data correct?
    boolean
    Date of signature
    Item
    Date of signature
    date
    Name of investigator
    Item
    Name of investigator
    text
    Tillbaka till toppen 

    Hjälp

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial